Friday, 02 December 2022

Boston Therapeutics poised to acquire MTA

13 April 2018 | News

The transaction, if consummated, will be an all-stock deal via a tax-free exchange of shares.

Singapore- Boston Therapeutics inks a non-binding letter of intent with Medical Technology Associates to acquire MTA, a privately-held company dedicated to the development of novel biopharmaceuticals through its proprietary ALTAPURE technology. ALTAPURE technology is a proprietary process for purification and stabilization applied to purify biological extractions, e.g. blood products (animal), pituitary gland, pancreas and botanicals, specialty proteins, creating molecules of enhanced purity (quality) for biopharmaceutical development and volume for commercialization (quantity in kilograms).    


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account